Year All202520242023202220182017 Date Title 17 Jan 2025 Illuccix Receives European Approval 13 Jan 2025 Telix JP Morgan Healthcare Conference 2025 Presentation 13 Jan 2025 Telix Exceeds FY24 Guidance with US$142M Q4 Revenue 13 Jan 2025 Proposed issue of securities - TLX 13 Jan 2025 Presentation to Accompany Biologics Platform Acquisition 13 Jan 2025 TLX to Acquire Next-Gen Therapeutics and Biologics Platform 09 Jan 2025 Notification of cessation of securities - TLX